Published in Farmaco on January 01, 1990
The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature (1999) 5.33
Coregulation of neurite outgrowth and cell survival by amphoterin and S100 proteins through receptor for advanced glycation end products (RAGE) activation. J Biol Chem (2000) 2.78
Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science (1997) 2.74
The p53/p63/p73 family of transcription factors: overlapping and distinct functions. J Cell Sci (2000) 2.55
Two new p73 splice variants, gamma and delta, with different transcriptional activity. J Exp Med (1998) 2.40
Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J Exp Med (1994) 2.18
Immunochemical and immuno-cytochemical localization of S-100 antigen in normal human skin. Nature (1981) 1.87
Heterogeneity within a large kindred with frontotemporal dementia: a novel progranulin mutation. Neurology (2007) 1.71
Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab. Br J Dermatol (2013) 1.60
Fas/Apo1 mutations and autoimmune lymphoproliferative syndrome in a patient with type 2 autoimmune hepatitis. Gastroenterology (1997) 1.58
Induction of the DNA-binding activity of c-jun/c-fos heterodimers by the hepatitis B virus transactivator pX. Mol Cell Biol (1994) 1.56
Excess of proton mean kinetic energy in supercooled water. Phys Rev Lett (2008) 1.39
Monoethylglycinexylidide production as a measure in predicting hepatic histology. Ital J Gastroenterol (1994) 1.38
Induction of neuronal differentiation by p73 in a neuroblastoma cell line. J Biol Chem (2000) 1.35
Nuclear factor kB-independent cytoprotective pathways originating at tumor necrosis factor receptor-associated factor 2. J Biol Chem (1998) 1.29
p63 and p73 transactivate differentiation gene promoters in human keratinocytes. Biochem Biophys Res Commun (2000) 1.28
S100B expression in and effects on microglia. Glia (2001) 1.28
Hydration of sodium, potassium, and chloride ions in solution and the concept of structure maker/breaker. J Phys Chem B (2007) 1.25
Resistance to Fas-mediated apoptosis in human hepatoma cells. Oncogene (1995) 1.23
Perturbation of water structure due to monovalent ions in solution. Phys Chem Chem Phys (2007) 1.21
Additional complexity in p73: induction by mitogens in lymphoid cells and identification of two new splicing variants epsilon and zeta. Cell Death Differ (1999) 1.20
S-100 proteins. Cell Calcium (1986) 1.17
Structure, function and regulation of p63 and p73. Cell Death Differ (1999) 1.12
Elevated serum levels of 90K/MAC-2 BP predict unresponsiveness to alpha-interferon therapy in chronic HCV hepatitis patients. J Hepatol (1996) 1.09
Apoptotic, non-apoptotic, and anti-apoptotic pathways of tumor necrosis factor signalling. Biochem Pharmacol (1998) 1.07
DNp73alpha protects myogenic cells from apoptosis. Oncogene (2006) 1.06
2-Arylpyrazolo[1,5-a]pyrimidin-3-yl acetamides. New potent and selective peripheral benzodiazepine receptor ligands. Bioorg Med Chem (2001) 1.05
Annexin V, annexin VI, S100A1 and S100B in developing and adult avian skeletal muscles. Neuroscience (2002) 1.02
S100B protects LAN-5 neuroblastoma cells against Abeta amyloid-induced neurotoxicity via RAGE engagement at low doses but increases Abeta amyloid neurotoxicity at high doses. J Neurosci Res (2006) 0.99
Free flaps in the treatment of locally advanced malignancy of the scalp and forehead. Ann Plast Surg (2002) 0.98
Induction of gene expression via activator protein-1 in the ascorbate protection against UV-induced damage. Biochem J (2001) 0.98
Nerve growth factor (NGF) influences differentiation and proliferation of myogenic cells in vitro via TrKA. Int J Dev Neurosci (2000) 0.97
HIPK2 phosphorylates ΔNp63α and promotes its degradation in response to DNA damage. Oncogene (2011) 0.97
Glassy dynamics and enzymatic activity of lysozyme. Phys Rev E Stat Nonlin Soft Matter Phys (2001) 0.97
S-100 protein, but not calmodulin, binds to the glial fibrillary acidic protein and inhibits its polymerization in a Ca(2+)-dependent manner. J Biol Chem (1993) 0.96
Nontuberculous mycobacteria in hospital water systems: application of HPLC for identification of environmental mycobacteria. J Water Health (2003) 0.96
Role of the C-terminal extension in the interaction of S100A1 with GFAP, tubulin, the S100A1- and S100B-inhibitory peptide, TRTK-12, and a peptide derived from p53, and the S100A1 inhibitory effect on GFAP polymerization. Biochem Biophys Res Commun (1999) 0.94
POEMS syndrome with vascular lesions: a role for interleukin-1beta and interleukin-6 increase--a case report. Angiology (1998) 0.94
Effects of S100A1 and S100B on microtubule stability. An in vitro study using triton-cytoskeletons from astrocyte and myoblast cell lines. Neuroscience (2000) 0.94
Moderate and severe plaque psoriasis: cost-of-illness study in Italy. Ther Clin Risk Manag (2008) 0.93
RelA/NF-kappaB recruitment on the bax gene promoter antagonizes p73-dependent apoptosis in costimulated T cells. Cell Death Differ (2007) 0.93
Association of S100B with intermediate filaments and microtubules in glial cells. Biochim Biophys Acta (1998) 0.92
Complement activation in hypercholesterolemia. Nutr Metab Cardiovasc Dis (2000) 0.92
Water and trehalose: how much do they interact with each other? J Phys Chem B (2010) 0.92
Mitogen-activated kinase kinase kinase 1 regulates T cell receptor- and CD28-mediated signaling events which lead to NF-kappaB activation. Eur J Immunol (2000) 0.92
Study of percolation and clustering in supercritical water-CO2 mixtures. J Chem Phys (2008) 0.91
Calcified disease of the mitral annulus: a spectrum of an evolving disease. Ann Cardiol Angeiol (Paris) (2011) 0.90
Bosentan treatment for Raynauds phenomenon and skin fibrosis in patients with Systemic Sclerosis and pulmonary arterial hypertension: an open-label, observational, retrospective study. Int J Immunopathol Pharmacol (2011) 0.89
Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases. Br J Dermatol (2004) 0.89
Improvement of psoriatic onychodystrophy by a water-soluble nail lacquer. J Eur Acad Dermatol Venereol (2009) 0.89
Time-dependent effect of statins on platelet function in hypercholesterolaemia. Eur J Clin Invest (2002) 0.89
Ions in water: the microscopic structure of concentrated NaOH solutions. J Chem Phys (2004) 0.88
Immunohistochemical localization of annexin V (CaBP33) in rat organs. J Histochem Cytochem (1991) 0.88
Proton glass freezing in hydrated lysozyme powders. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics (1999) 0.88
S-100 protein binds to annexin II and p11, the heavy and light chains of calpactin I. Biochim Biophys Acta (1992) 0.87
Soluble and membrane-bound S-100 protein in cerebral cortex synaptosomes. Properties of the S-100 receptor. Brain Res (1975) 0.87
Ions in water: the microscopic structure of a concentrated HCl solution. J Chem Phys (2004) 0.87
Photometric assay for polynucleotide phosphorylase. Anal Biochem (1999) 0.87
Laparoscopic treatment of bowel endometriosis in infertile women. Hum Reprod (2009) 0.87
S-100a0 protein stimulates Ca2+-induced Ca2+ release from isolated sarcoplasmic reticulum vesicles. FEBS Lett (1989) 0.86
Two-dimensional protonic percolation on lightly hydrated purple membrane. Proc Natl Acad Sci U S A (1988) 0.86
S-100 (alpha and beta) binding peptide (TRTK-12) blocks S-100/GFAP interaction: identification of a putative S-100 target epitope within the head domain of GFAP. Biochim Biophys Acta (1996) 0.86
Treasure or artifact: a decade of p63 research speaks for itself. Cell Death Differ (2010) 0.86
Structure and dynamics of water confined in silica hydrogels: X-ray scattering and dielectric spectroscopy studies. Eur Phys J E Soft Matter (2003) 0.86
Structural and functional abnormality of systemic microvessels in cardiac syndrome X. Nutr Metab Cardiovasc Dis (2005) 0.86
Primary supraceliac aortic pseudoaneurysm due to a septic aortic rupture. J Cardiovasc Surg (Torino) (2005) 0.85
Multiscale approach to the structural study of water confined in MCM41. J Phys Chem B (2009) 0.85
Annexin VI binds S100A1 and S100B and blocks the ability of S100A1 and S100B to inhibit desmin and GFAP assemblies into intermediate filaments. Cell Calcium (1998) 0.85
Cytokine expression in circulating T lymphocytes from patients undergoing carotid endarterectomy. J Cardiovasc Surg (Torino) (2003) 0.84
S100A1 and S100B interactions with annexins. Biochim Biophys Acta (2000) 0.84
Viscosity of aqueous solutions and local microscopic structure. J Phys Chem B (2011) 0.84
Membrane-bound annexin V isoforms (CaBP33 and CaBP37) and annexin VI in bovine tissues behave like integral membrane proteins. FEBS Lett (1992) 0.84
Proton tunneling in hydrated biological tissues near 200 K. Biophys Chem (1990) 0.83
Replicating myoblasts and fused myotubes express the calcium-regulated proteins S100A1 and S100B. Cell Calcium (1999) 0.83
Effects of calcium-binding proteins (S-100a(o), S-100a, S-100b) on desmin assembly in vitro. FASEB J (1996) 0.83
Leukemia inhibitory factor enhances the regeneration of transected rat sciatic nerve and the function of reinnervated muscle. J Neurosci Res (1997) 0.83
Annexin II2-p11(2) (calpactin I) stimulates the assembly of GFAP in a calcium- and pH-dependent manner. Biochem Biophys Res Commun (1995) 0.83
[Structure and antipyretic-hypothermizing effect of various pyrazol/1,5-a/pyrimidines]. Farmaco Sci (1979) 0.83
Atorvastatin reduces platelet-oxidized-LDL receptor expression in hypercholesterolaemic patients. Eur J Clin Invest (2005) 0.83
Annexin-immunoreactive proteins in the nervous system and eye of the gastropods, Aplysia and Helix. Brain Res (1997) 0.82
Immunocytochemical localization of S-100b protein in degenerating and regenerating rat sciatic nerves. J Histochem Cytochem (1989) 0.82
Mechanism of S100 protein-dependent inhibition of glial fibrillary acidic protein (GFAP) polymerization. Biochim Biophys Acta (1994) 0.82
The specific interaction of S-100 protein with synaptosomal particulate fractions. Site-site interactions among S-100 binding sites. J Neurochem (1978) 0.82
Actinic keratosis treated with an immune response modifier: a case report of six patients. Clin Exp Dermatol (2003) 0.82
S100B and S100A1 proteins in bovine retina:their calcium-dependent stimulation of a membrane-bound guanylate cyclase activity as investigated by ultracytochemistry. Neuroscience (1999) 0.82
Effect of Pidotimod, a new immunostimulating agent, on some aspects of immune response. In vitro study. Pharmacol Res (1992) 0.82
Prosaposin is immunolocalized to muscle and prosaptides promote myoblast fusion and attenuate loss of muscle mass after nerve injury. Muscle Nerve (2001) 0.81
Effect of diet and treatment with statins on platelet-dependent thrombin generation in hypercholesterolemic subjects. Nutr Metab Cardiovasc Dis (2001) 0.81
Characterization of type III intermediate filament regulatory protein target epitopes: S-100 (beta and/or alpha) binds the N-terminal head domain; annexin II2-p11(2) binds the rod domain. Biochim Biophys Acta (1996) 0.81
[Pidotimod, a new biological response modifier, is able to partially prevent immune response changes related to surgical stress]. Drugs Exp Clin Res (1993) 0.81
Annexin V as a probe of the contribution of anionic phospholipids to the procoagulant activity of tumour cell surfaces. Blood Coagul Fibrinolysis (1994) 0.81
Specific binding sites for S-100 protein in isolated brain nuclei. J Neurochem (1981) 0.81
Eigen versus Zundel complexes in HCl-water mixtures. J Chem Phys (2006) 0.81
Ions in water: the microscopic structure of concentrated hydroxide solutions. J Chem Phys (2005) 0.81
Proton momentum distribution in a protein hydration shell. Phys Rev Lett (2007) 0.80
Efficacy of monochromatic excimer laser radiation (308 nm) in the treatment of early stage mycosis fungoides. Br J Dermatol (2004) 0.80